Swiss National Bank - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 201 filers reported holding AMICUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,705,472
-1.6%
469,200
+1.6%
0.00%0.0%
Q2 2023$5,797,696
+14.9%
461,600
+1.5%
0.00%
+33.3%
Q1 2023$5,043,732
-18.7%
454,800
-10.5%
0.00%
-25.0%
Q4 2022$6,202,680
+19.2%
508,000
+1.9%
0.00%0.0%
Q3 2022$5,202,000
-2.1%
498,300
+0.7%
0.00%0.0%
Q2 2022$5,313,000
+6.4%
494,700
-6.1%
0.00%
+33.3%
Q1 2022$4,992,000
-8.1%
527,100
+12.1%
0.00%0.0%
Q4 2021$5,432,000
+21.0%
470,3000.0%0.00%0.0%
Q3 2021$4,491,000
-0.0%
470,300
+0.9%
0.00%0.0%
Q2 2021$4,493,000
-15.1%
466,100
-13.0%
0.00%
-25.0%
Q1 2021$5,295,000
-56.5%
535,900
+1.8%
0.00%
-55.6%
Q4 2020$12,159,000
+63.8%
526,600
+0.2%
0.01%
+50.0%
Q3 2020$7,421,000
-13.5%
525,600
-7.6%
0.01%
-14.3%
Q2 2020$8,578,000
+87.9%
568,800
+15.1%
0.01%
+40.0%
Q1 2020$4,566,000
-3.8%
494,200
+1.4%
0.01%0.0%
Q4 2019$4,747,000
+36.4%
487,400
+12.3%
0.01%
+25.0%
Q3 2019$3,481,000
-33.0%
434,100
+4.3%
0.00%
-33.3%
Q2 2019$5,194,000
+10.7%
416,200
+20.6%
0.01%
+20.0%
Q1 2019$4,692,000
+46.4%
345,000
+3.2%
0.01%
+25.0%
Q4 2018$3,204,000
-19.4%
334,400
+1.7%
0.00%0.0%
Q3 2018$3,974,000
-21.2%
328,700
+1.8%
0.00%
-33.3%
Q2 2018$5,044,000
+3.9%
322,9000.0%0.01%0.0%
Q1 2018$4,856,000
+33.8%
322,900
+28.0%
0.01%
+50.0%
Q4 2017$3,629,000
+0.1%
252,200
+5.0%
0.00%0.0%
Q3 2017$3,624,000
+71.1%
240,300
+14.3%
0.00%
+33.3%
Q2 2017$2,118,000
+41.3%
210,3000.0%0.00%
+50.0%
Q1 2017$1,499,000
+43.4%
210,3000.0%0.00%0.0%
Q4 2016$1,045,000
-22.6%
210,300
+15.2%
0.00%0.0%
Q3 2016$1,351,000
+35.5%
182,6000.0%0.00%0.0%
Q2 2016$997,000
-33.0%
182,6000.0%0.00%
-33.3%
Q1 2016$1,489,000
+9.5%
182,600
+30.2%
0.00%0.0%
Q4 2015$1,360,000
-28.0%
140,200
+3.8%
0.00%
-40.0%
Q3 2015$1,890,000
+13.1%
135,100
+14.4%
0.01%
+25.0%
Q2 2015$1,671,000
+93.4%
118,100
+48.7%
0.00%
+100.0%
Q1 2015$864,000
+63.9%
79,400
+25.2%
0.00%0.0%
Q4 2014$527,00063,4000.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Morgenthaler Management Partners IX, LLC 1,783,948$17,304,00018.83%
FRAZIER MANAGEMENT LLC 2,918,291$28,307,00011.84%
Avoro Capital Advisors LLC 3,515,611$34,101,00011.75%
Perceptive Advisors 15,239,444$147,823,00010.94%
Redmile Group, LLC 10,280,620$99,722,0007.46%
ACUTA CAPITAL PARTNERS, LLC 1,502,661$14,576,0006.97%
SECTORAL ASSET MANAGEMENT INC 7,973,436$77,342,0003.30%
Asymmetry Capital Management, L.P. 195,206$1,893,0002.86%
Convector Capital Management, LP 210,500$2,042,0001.92%
Palo Alto Investors LP 3,551,173$34,446,0001.92%
View complete list of AMICUS THERAPEUTICS INC shareholders